Drug intelligence / Profile preview

duloxetine + magnesium sulphate

Development stage
Approved
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

This is a combination of two active pharmaceutical ingredients: **duloxetine**, a serotonin-norepinephrine reuptake inhibitor (SNRI) primarily used to treat major depressive disorder, generalized anxiety disorder, neuropathic pain, fibromyalgia, and chronic musculoskeletal pain; and **magnesium sulphate**, an inorganic salt used as an anticonvulsant in eclampsia/pre-eclampsia, as a laxative for constipation, and for electrolyte replenishment. Duloxetine acts by inhibiting the reuptake of serotonin and norepinephrine in the central nervous system. Magnesium sulphate works by modulating neuromuscular transmission and acting as a smooth muscle relaxant. This combination is not marketed under a unique brand name but may be co-administered clinically to manage both psychiatric symptoms (with duloxetine) and constipation or electrolyte imbalance (with magnesium sulphate). There are no highly clinically significant interactions reported between these two drugs; however, some evidence suggests that certain forms of magnesium can reduce serum concentrations of duloxetine via physicochemical interaction affecting absorption[1][4][5][6].

Other names
duloxetine and magnesium sulfateduloxetine plus magnesium sulfate
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on duloxetine + magnesium sulphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on duloxetine + magnesium sulphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call